Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort

Stock Information for Australis Capital Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Australis Capital Inc - Ordinary Shares

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference
Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting
Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference
Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels
European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.